Home / France / Teleperformance

Teleperformance

Short position disclosed on September 22, 2026.

7.30% of the capital sold short

8 disclosing funds

683 disclosures on record

FR0000051807 ISIN code 301 292 702 SIREN

Evolution of the disclosed total

0%5%10%15%

Oct 2025Jan 2026Apr 2026Jul 2026

Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Over the whole history, the total peaked at 13.82% on July 14, 2026. The shaded band matches the twelve months of the first chart.

November 30, 2017 today

Open positions

The funds disclosing a short position that is still open.
Fund	% of capital	Over the year	Since	Filing
Marshall Wace LLP	1.60%	new	September 18, 2026
Jericho Capital Asset Management L.P.	1.18%	unchanged	June 4, 2025	AMF
Citadel Advisors LLC	1.11%	new	September 21, 2026
POINT72 Asset Management, L.P.	1.02%	-0.52 pt	September 22, 2026
Squarepoint OPS LLC	0.78%	new	September 3, 2026
Exoduspoint Capital Management, LP	0.60%	new	September 18, 2026
D. E. Shaw & CO., L.P.	0.51%	-0.19 pt	August 18, 2026	AMF
AQR Capital Management, LLC	0.50%	-0.30 pt	September 11, 2026

In the United States TLPFF (OTC): 300,891 shares sold short on August 31, 2026. FINRA names no fund.

On the other side: the funds that hold Teleperformance Titelia

Follow by RSS

Get the moves on Teleperformance by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

683 disclosures on record for this share.
Date	Fund	% of capital	End of publication
February 28, 2024	Marshall Wace LLP	0.49%	March 1, 2024
February 27, 2024	Marshall Wace LLP	0.66%	March 1, 2024
February 21, 2024	Marshall Wace LLP	0.79%	March 1, 2024
February 19, 2024	Marshall Wace LLP	0.87%	March 1, 2024
February 14, 2024	Qube Research & Technologies Limited	0.64%	March 28, 2024
February 13, 2024	Marshall Wace LLP	0.90%	March 1, 2024
February 13, 2024	Qube Research & Technologies Limited	0.70%	March 28, 2024
February 9, 2024	Qube Research & Technologies Limited	0.69%	March 28, 2024
February 7, 2024	Marshall Wace LLP	0.80%	March 1, 2024
February 1, 2024	Qube Research & Technologies Limited	0.49%	February 5, 2024
January 31, 2024	Marshall Wace LLP	0.71%	March 1, 2024
January 30, 2024	Qube Research & Technologies Limited	0.51%	February 5, 2024
January 29, 2024	Marshall Wace LLP	0.69%	March 1, 2024
January 19, 2024	Marshall Wace LLP	0.79%	March 1, 2024
December 29, 2023	Marshall Wace LLP	0.83%	March 1, 2024
December 22, 2023	Marshall Wace LLP	0.79%	March 1, 2024
December 12, 2023	Marshall Wace LLP	0.89%	March 1, 2024
December 6, 2023	Marshall Wace LLP	0.97%	March 1, 2024
November 23, 2023	Qube Research & Technologies Limited	0.49%	November 27, 2023
November 20, 2023	Qube Research & Technologies Limited	0.50%	November 27, 2023
November 14, 2023	Marshall Wace LLP	1.00%	March 1, 2024
November 8, 2023	Gladstone Capital Management LLP	0.48%	November 10, 2023
November 2, 2023	Gladstone Capital Management LLP	0.59%	November 10, 2023
November 1, 2023	Gladstone Capital Management LLP	0.61%	November 10, 2023
October 30, 2023	Marshall Wace LLP	0.99%	March 1, 2024
October 30, 2023	Qube Research & Technologies Limited	0.49%	November 1, 2023
October 26, 2023	Marshall Wace LLP	1.07%	March 1, 2024
October 26, 2023	Qube Research & Technologies Limited	0.53%	November 1, 2023
October 24, 2023	Marshall Wace LLP	1.11%	March 1, 2024
October 20, 2023	Perbak Capital Partners LLP	0.47%	October 24, 2023
October 17, 2023	Perbak Capital Partners LLP	0.57%	October 24, 2023
September 27, 2023	Perbak Capital Partners LLP	0.60%	October 24, 2023
September 13, 2023	Perbak Capital Partners LLP	0.52%	October 24, 2023
September 11, 2023	Marshall Wace LLP	1.01%	March 1, 2024
September 1, 2023	Perbak Capital Partners LLP	0.49%	September 5, 2023
August 22, 2023	Marshall Wace LLP	0.91%	March 1, 2024
August 18, 2023	Marshall Wace LLP	0.84%	March 1, 2024
August 15, 2023	Marshall Wace LLP	0.70%	March 1, 2024
August 11, 2023	Perbak Capital Partners LLP	0.54%	September 5, 2023
August 9, 2023	Marshall Wace LLP	0.61%	March 1, 2024
August 7, 2023	Marshall Wace LLP	0.53%	March 1, 2024
August 2, 2023	Perbak Capital Partners LLP	0.49%	August 4, 2023
August 1, 2023	Gladstone Capital Management LLP	0.51%	November 10, 2023
July 7, 2023	Marshall Wace LLP	0.47%	July 11, 2023
July 6, 2023	Perbak Capital Partners LLP	0.51%	August 4, 2023
June 22, 2023	Marshall Wace LLP	0.51%	July 11, 2023
June 14, 2023	Perbak Capital Partners LLP	0.46%	June 16, 2023
June 13, 2023	Marshall Wace LLP	0.46%	June 15, 2023
May 25, 2023	Perbak Capital Partners LLP	0.50%	June 16, 2023
May 19, 2023	Marshall Wace LLP	0.50%	June 15, 2023

The AMF column opens the filing the fund itself lodged, on the regulator own site.

Download 683 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in France

Ubisoft Entertainment 12.45% of the capital sold short
Valeo 11.40% of the capital sold short
Renault 9.27% of the capital sold short
Viridien 8.39% of the capital sold short
FDJ United 6.19% of the capital sold short
Abivax 5.03% of the capital sold short
Alstom 4.57% of the capital sold short
Elis 4.57% of the capital sold short
Rémy Cointreau 4.46% of the capital sold short
VusionGroup 4.02% of the capital sold short
Sopra Steria Group 3.90% of the capital sold short
DBV Technologies 3.70% of the capital sold short

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Teleperformance, source AMF, data as at September 22, 2026, https://www.quivad.com/action/teleperformance?page=13